Cardiovascular Clinical Studies

This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.

Siemens Artis Q angiography system #ESC #ESCcongress
News | Sudden Cardiac Arrest | September 13, 2021
September 13, 2021 — Early coronary angiography in out-of-hospital cardiac arrest (OHCA) patients without ST-segment...
Systematic FFR Assessment Did Not Add Benefit During Diagnostic Angiography.
News | FFR Technologies | September 08, 2021
September 8, 2021 — Adding systematic fractional flow reserve (FFR) assessment to coronary angiography does not reduce...
A 3-D CT reconstructed image showing a narrow lesion at the carotid bifurcation. ACST-2 was the largest trial to compare the long-term effect of carotid artery stenting (CAS) and carotid endarterectomy (CEA) on stroke in asymptomatic patients with a severely narrowed carotid artery that had not yet caused a stroke. Image by Canon

A 3-D CT reconstructed image showing a narrow lesion at the carotid bifurcation. ACST-2 was the largest trial to compare the long-term effect of carotid artery stenting (CAS) and carotid endarterectomy (CEA) on stroke in asymptomatic patients with a severely narrowed carotid artery that had not yet caused a stroke. Image by Canon

News | Stroke | September 07, 2021
September 7, 2021 — Carotid artery surgery and stenting have comparable long-term effects on fatal or disabling stroke...
The Medtronic Reveal Linq implantable cardiac monitor (ICM) was used in the SMART-MI study. It is inserted under the skin in a simple, fast outpatient procedure. The device is smaller than a AAA battery.

The Medtronic Reveal Linq implantable cardiac monitor (ICM) was used in the SMART-MI study. It is inserted under the skin in a simple, fast outpatient procedure. The device is smaller than a AAA battery.

News | Implantable Cardiac Monitor (ICM) | September 07, 2021
September 7, 2021 — Remote monitoring of implantable cardiac monitors (ICMs) is highly effective for early detection of...
COVID in cardiology was again a key driver of content pageviews on DAIC in August 2021. Also, a key new technology that cardiologists had a lot of interest in was the release of 3D/4D intra-cardiac echocardiography (ICE) to better guide EP and structural heart procedures without the need for transesophageal echo and its associated need for deep anesthesia. 

COVID in cardiology was again a key driver of content pageviews on DAIC in August 2021. Also, a key new technology that cardiologists had a lot of interest in was the release of 3D/4D intra-cardiac echocardiography (ICE) to better guide EP and structural heart procedures without the need for transesophageal echo and its associated need for deep anesthesia. This was the topic of two articles from Northwestern Medicine and Mayo Clinic in the top content this month.

Feature | September 03, 2021 | By Dave Fornell, Editor
September 3, 2021 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC...
Drones Could Deliver Defibrillators or AEDs to sudden Cardiac Arrest Victims Faster Than Ambulances. Getty Images

Getty Images

Feature | Sudden Cardiac Arrest | September 01, 2021
September 1, 2021 — The world’s first feasibility study has found that drones can be used to deliver life-saving...
One-month Clopidogrel Monotherapy After PCI Not Supported in STOPDAPT-2 ACS Trial 
News | Antiplatelet and Anticoagulation Therapies | September 01, 2021
September 1, 2021 — The STOPDAPT-2 ACS trial does not support the use of one month of dual antiplatelet therapy (DAPT)...
The anticoagulant edoxaban (Savaysa) may be just as effective as warfarin for preventing heart attack or stroke in patients with AFib who undergo transcatheter aortic valve replacement (TAVR), according to an ESC late-breaking trial.

The anticoagulant edoxaban (Savaysa) may be just as effective as warfarin for preventing heart attack or stroke in patients with AFib who undergo transcatheter aortic valve replacement (TAVR), according to an ESC late-breaking trial.

News | Antiplatelet and Anticoagulation Therapies | September 01, 2021
September 1, 2021 – The anticoagulant edoxaban (Savaysa) may be just as effective as warfarin for preventing heart...
Abbott Amplatzer Amulet LAA Occluder Offers Superior Closure Compared to Watchman
News | Left Atrial Appendage (LAA) Occluders | August 31, 2021
August 31, 2021 — Late-breaking data from a head-to-head clinical trial of the Amulet Left Atrial Appendage (LAA)...
The American Heart Association announced its support this week for the CDC and FDA recommendation that immuno-compromised patients should receive a third dose of the Pfizer or Moderna COVID vaccines. Getty Images #AHA #coronavirus #COVID19

The American Heart Association announced its support this week for the CDC and FDA recommendation that immuno-compormised patients should receive a third dose of the Pfizer or Moderna COVID vaccines. Getty Images

News | Coronavirus (COVID-19) | August 18, 2021 | By Dave Fornell, Editor
August 18, 2021 — The U.S. Centers for Disease Control and Prevention (CDC) recommended Friday a third dose of the...
Boston Scientific Corp. has commenced enrollment in the HI-PEITHO clinical trial, a collaborative research study with the Pulmonary Embolism Response Team (PERT) Consortium and the University Medical Center of the Johannes Gutenberg University of Mainz comparing use of the EkoSonic Endovascular System in combination with anticoagulation to anticoagulation alone for the treatment of acute, intermediate-high-risk pulmonary embolism (PE).
News | Pulmonary Embolism | August 09, 2021
August 9, 2021 — Boston Scientific Corp. has commenced enrollment in the HI-PEITHO clinical trial, a collaborative...
Ventricular Tachycardia Recurrence, Hospitalization and Death Reduced With Catheter Ablation as First Line Therapy. Results from an international clinical trial show a significant reduction in risk of ventricular tachycardia (VT) recurrence, cardiovascular hospitalization, and sudden cardiac death (SCD) death when catheter ablation is used as an early first-line treatment for patients with structural heart disease. Led by study coordinating center, the University of Chicago, The PAUSE-SCD trial. #HRS21
News | EP Lab | August 09, 2021
August 9, 2021 – Results from an international clinical trial show a significant reduction in risk of ventricular...
The Adagio Medical iCLAS cryoablation system is commercial in Europe and is also part of an ongoing FDA IDE trial in the U.S. #HRS21
News | Atrial Fibrillation | August 09, 2021
August 9, 2021 — Adagio Medical Inc., a provider of catheter ablation technologies for atrial fibrillation (AF) and...
EP lab ablation catheter. #HRS21 #HRS2021
News | EP Lab | August 03, 2021
August 3, 2021 — A subgroup analysis of the EAST – AFNET 4 study population revealed early initiation of rhythm control...
emporary Spinal cord stimulation (SCS) was effective in suppressing post-operative atrial fibrillation (AF) after coronary artery bypass (CAGB) surgery CABG without any adverse events in a randomized pilot study. The TEmporary Spinal CoRd StiMulatIon to PrevenNt Atrial FibrillaTION AFter Cardiac Surgery (TerminationAF) study was presented as a late-breaking study presented at the 2021 Heart Rhythm meeting, the annual conference of the Heart Rhythm Society (HRS).  #HRS21 #HRS2021
News | EP Lab | August 03, 2021
August 4, 2021 — Temporary Spinal cord stimulation (SCS) was effective in suppressing post-operative atrial...